Screener
Recognized revenue
Zevra Therapeutics, Inc.·Products & Services·1 segment·Rolls up to Revenue recognized that was included in deferred income at the beginning of the period
Breakdown
Segments
LicenseView metric
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| License | $1.3M | $1.1M | -$3.6M | $900K | $1.2M | $0 | $0 | $300K |
| Total | — | — | — | — | — | — | — | — |